Stock analysis, AI verdict, fundamentals & technical signals
Rating: NEUTRAL
Price: $178.80 Analyst target: $202.24 Upside: 13.11%
Guardant Health, Inc., a precision oncology company, offers blood testing, data sets, and testing in the United States and internationally. The company is headquartered in Redwood City, California.
See the full interactive analysis & chart →Informational only — not investment advice.